Best Growth Stocks To Follow Today – June 11th

Circle Internet Group, Novo Nordisk A/S, Kazia Therapeutics, Blueprint Medicines, and BlackRock are the five Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares of companies expected to grow their revenues and earnings at an above-average rate compared to the broader market. Investors buy them in anticipation that rapid expansion—driven by factors like innovative products, market share gains, or reinvestment of profits—will translate into higher stock prices over time. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Circle Internet Group (CRCL)

Founded in 2013, Circle’s mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.

Shares of NYSE CRCL traded up $11.35 during mid-day trading on Wednesday, reaching $117.26. The company had a trading volume of 17,736,361 shares, compared to its average volume of 37,100,797. Circle Internet Group has a 12-month low of $64.00 and a 12-month high of $138.57.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of Novo Nordisk A/S stock traded down $0.04 on Wednesday, hitting $79.29. 5,181,531 shares of the company traded hands, compared to its average volume of 6,952,500. The company has a quick ratio of 0.55, a current ratio of 0.74 and a debt-to-equity ratio of 0.62. Novo Nordisk A/S has a 12-month low of $57.00 and a 12-month high of $148.15. The company has a 50-day moving average price of $66.26 and a 200 day moving average price of $80.17. The company has a market cap of $355.83 billion, a PE ratio of 24.07, a PEG ratio of 0.90 and a beta of 0.66.

Kazia Therapeutics (KZIA)

Kazia Therapeutics Limited operates as an oncology-focused biotechnology company. The company’s lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/AKT/mTOR pathway, which is developed as a potential therapy for glioblastoma. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3.

Shares of NASDAQ KZIA traded up $4.17 during trading hours on Wednesday, hitting $9.43. The stock had a trading volume of 42,618,461 shares, compared to its average volume of 346,686. The firm’s 50-day moving average price is $3.76 and its two-hundred day moving average price is $7.66. Kazia Therapeutics has a 52 week low of $2.86 and a 52 week high of $79.00.

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.

BPMC stock traded down $0.03 during trading hours on Wednesday, hitting $127.95. The company’s stock had a trading volume of 2,549,418 shares, compared to its average volume of 1,158,626. The stock has a 50 day moving average price of $97.16 and a two-hundred day moving average price of $96.33. Blueprint Medicines has a 12 month low of $73.04 and a 12 month high of $128.24. The company has a market capitalization of $8.26 billion, a PE ratio of -118.47 and a beta of 0.84. The company has a quick ratio of 2.80, a current ratio of 2.85 and a debt-to-equity ratio of 1.15.

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Shares of BLK stock traded up $8.34 on Wednesday, hitting $1,000.24. The company’s stock had a trading volume of 237,966 shares, compared to its average volume of 687,135. The stock has a market capitalization of $154.96 billion, a price-to-earnings ratio of 23.80, a P/E/G ratio of 1.90 and a beta of 1.41. BlackRock has a fifty-two week low of $752.30 and a fifty-two week high of $1,084.22. The firm’s fifty day moving average price is $927.88 and its 200-day moving average price is $972.57. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.23 and a quick ratio of 5.23.